journal article·2026-04Open access

Electro‐Stimulated Graphene‐Polymer Nanocomposites Enable Wearable Patches With Feedback‐Controlled Drug Release

Santosh K. Misra, Ketan Dighe, Pranay Saha, Teresa Aditya, Muhammad S. Khan, Maha Alafeef, Parikshit Moitra, Dipanjan Pan

Advanced Healthcare Materials· Volume 15· Issue 15

Abstract

ABSTRACT Stimuli‐responsive nanomaterials capable of spatiotemporal control over drug release are of nanocomposite patch (“e‐Medi‐Patch”) engineered from biodegradable polycaprolactone (PCL), graphene nanoplatelets, and a redox‐active therapeutic, niclosamide. The hierarchical composite integrates π‐π interactions between aromatic drug molecules and conductive graphene to enhance loading and retention, an Au microelectrode interface to enable wireless electrostimulation, and bluetooth‐assisted impedance sensing for real‐time monitoring of release dynamics. Under mild electrical stimulation, the nanocomposite exhibits on‐demand, unidirectional release of niclosamide with tunable kinetics, confirmed by modelling, in vitro melanoma cell studies, and in vivo xenograft tumor regression. Unlike conventional slow‐release patches that rely on passive diffusion, the e‐Medi‐Patch uniquely offers on‐demand electrostimulatory release with real‐time feedback monitoring, transforming drug delivery from a static system into an actively controlled, intelligent therapeutic platform. Beyond melanoma, the platform accommodates other redox‐active therapeutics and offers scalable melt‐blending fabrication. This work establishes an integrated materials‐electronics strategy for wearable, feedback‐controlled drug delivery, bridging multifunctional nanocomposites and precision medicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Sensor and Energy Harvesting Materials · Graphene and Nanomaterials Applications · Dielectric materials and actuators

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Bioengineering Department University of Illinois at Urbana‐Champaign Urbana USA

Department of Biological Sciences & Bioengineering Indian Institute of Technology Kanpur UP India

Department of Biomedical Engineering The Pennsylvania State University University Park PA USA

Department of Nuclear Engineering The Pennsylvania State University Hallowell Building University Park PA USA

Cardiovascular Research and Training Institute The University of Utah Salt Lake City UT USA

Biomedical Engineering Department Jordan University of Science and Technology Irbid Jordan

Department of Materials Science and Engineering The Pennsylvania State University University Park PA USA

Department of Chemistry The Pennsylvania State University University Park PA USA

Huck Institutes of Life Sciences Millennium Science Complex The Pennsylvania State University University Park PA USA

References (74)

Show source-provided references
1. 10.1002/smll.20240620610.1002/smll.202406206 ↗
2. 10.1002/smll.20180198310.1002/smll.201801983 ↗
3. 10.1002/adfm.20150484610.1002/adfm.201504846 ↗
4. 10.1016/j.bios.2025.11733310.1016/j.bios.2025.117333 ↗
5. 10.1002/smll.20241210710.1002/smll.202412107 ↗
6. 10.1016/j.bios.2022.11400710.1016/j.bios.2022.114007 ↗
7. 10.1021/acs.analchem.6b0476910.1021/acs.analchem.6b04769 ↗
8. 10.1002/smtd.20200009910.1002/smtd.202000099 ↗
9. 10.1002/admi.20210187410.1002/admi.202101874 ↗
10. 10.1039/c002690p10.1039/c002690p ↗
11. 10.1016/j.jconrel.2013.10.01710.1016/j.jconrel.2013.10.017 ↗
12. 10.1039/D2SC00260D10.1039/D2SC00260D ↗
13. 10.1002/mds3.1006910.1002/mds3.10069 ↗
14. 10.1021/acs.chemrev.5b0034610.1021/acs.chemrev.5b00346 ↗
15. 10.3390/pharmaceutics1705057910.3390/pharmaceutics17050579 ↗
16. 10.1038/s41528-023-00270-310.1038/s41528-023-00270-3 ↗
17. 10.1021/acsami.2c0595210.1021/acsami.2c05952 ↗
18. 10.1002/adma.20231011010.1002/adma.202310110 ↗
19. 10.1039/D3NH00578J10.1039/D3NH00578J ↗
20. 10.1021/acs.accounts.7b0054910.1021/acs.accounts.7b00549 ↗
21. 10.1039/C5CS00798D10.1039/C5CS00798D ↗
22. 10.1039/C7CS00663B10.1039/C7CS00663B ↗
23. 10.3390/pharmaceutics1508216510.3390/pharmaceutics15082165 ↗
24. 10.1039/D0RA00735H10.1039/D0RA00735H ↗
25. 10.2174/138920021866617022215055510.2174/1389200218666170222150555 ↗
26. 10.3389/fnano.2022.100662810.3389/fnano.2022.1006628 ↗
27. 10.1038/nrd130410.1038/nrd1304 ↗
28. 10.1002/jbm.b.3273210.1002/jbm.b.32732 ↗
29. 10.1038/s41598‐023‐34217‐510.1038/s41598‐023‐34217‐5 ↗
30. 10.1016/j.ijpharm.2008.03.03210.1016/j.ijpharm.2008.03.032 ↗
31. 10.1021/acs.molpharmaceut.4c0021110.1021/acs.molpharmaceut.4c00211 ↗
32. 10.1016/j.ejps.2018.03.02010.1016/j.ejps.2018.03.020 ↗
33. 10.1002/adhm.20170000810.1002/adhm.201700008 ↗
34. 10.1039/C7AN01932G10.1039/C7AN01932G ↗
35. 10.1021/acsnano.4c0140010.1021/acsnano.4c01400 ↗
36. 10.1002/jps.2200410.1002/jps.22004 ↗
37. 10.1016/j.ejpb.2006.03.00910.1016/j.ejpb.2006.03.009 ↗
38. 10.1016/j.jconrel.2010.08.01510.1016/j.jconrel.2010.08.015 ↗
39. Technologies in Transdermal Drug Delivery System: A Review
40. 10.1016/S0939‐6411(01)00166‐710.1016/S0939‐6411(01)00166‐7 ↗
41. 10.4314/tjpr.v8i2.4452710.4314/tjpr.v8i2.44527 ↗
42. 10.1016/S0928‐0987(01)00167‐110.1016/S0928‐0987(01)00167‐1 ↗
43. The Cost of Unsafe Injections
44. 10.1007/BF0335368410.1007/BF03353684 ↗
45. 10.1016/j.bios.2018.08.01910.1016/j.bios.2018.08.019 ↗
46. 10.1021/acsnano.4c0179210.1021/acsnano.4c01792 ↗
47. W.Zhen D.Enrique P.Debanjan andP.Dipanjan 2017.
48. 10.1021/acs.chemrev.3c0082310.1021/acs.chemrev.3c00823 ↗
49. 10.1016/j.progpolymsci.2010.04.00210.1016/j.progpolymsci.2010.04.002 ↗
50. 10.1021/mp300195210.1021/mp3001952 ↗
51. 10.1016/j.ijpharm.2025.12609910.1016/j.ijpharm.2025.126099 ↗
52. 10.1109/JSEN.2007.91252210.1109/JSEN.2007.912522 ↗
53. 10.1016/j.mtchem.2022.10098710.1016/j.mtchem.2022.100987 ↗
54. 10.1021/acsmaterialsau.3c0002710.1021/acsmaterialsau.3c00027 ↗
55. 10.1016/j.jconrel.2023.01.04610.1016/j.jconrel.2023.01.046 ↗
56. 10.1111/ics.1282410.1111/ics.12824 ↗
57. 10.1016/j.addr.2020.09.01110.1016/j.addr.2020.09.011 ↗
58. 10.1021/acsaelm.5c0005010.1021/acsaelm.5c00050 ↗
59. 10.1016/j.mattod.2025.05.01910.1016/j.mattod.2025.05.019 ↗
60. 10.1016/j.addr.2012.07.01610.1016/j.addr.2012.07.016 ↗
61. 10.1016/j.jconrel.2011.05.00310.1016/j.jconrel.2011.05.003 ↗
62. 10.1016/j.addr.2014.01.00710.1016/j.addr.2014.01.007 ↗
63. 10.1088/0960‐1317/23/3/03502610.1088/0960‐1317/23/3/035026 ↗
64. 10.1016/j.addr.2013.05.01010.1016/j.addr.2013.05.010 ↗
65. 10.1002/j.1460‐2075.1982.tb01257.x10.1002/j.1460‐2075.1982.tb01257.x ↗
66. 10.1073/pnas.90.22.1050410.1073/pnas.90.22.10504 ↗
67. Iontophoretic Drug Delivery: History and Applications
68. 10.1023/A:101589401623510.1023/A:1015894016235 ↗
69. 10.1016/j.ejps.2015.02.01210.1016/j.ejps.2015.02.012 ↗
70. 10.1016/j.addr.2012.04.01210.1016/j.addr.2012.04.012 ↗
71. 10.1016/j.ijpharm.2015.02.02410.1016/j.ijpharm.2015.02.024 ↗
72. 10.1039/C5NR00403A10.1039/C5NR00403A ↗
73. 10.1016/j.bbagen.2020.12984110.1016/j.bbagen.2020.129841 ↗
74. 10.1021/acsami.2c0390510.1021/acsami.2c03905 ↗